Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Willem N Hustinx
Effectiveness of Discontinuing Antibiotic Treatment After Three Days Versus Eight Days in Mild to Moderate-Severe Community Acquired Pneumonia: Randomised, Double Blind Study
BMJ
Related publications
Antibiotic Treatment for 6 Days Versus 12 Days in Patients With Severe Cellulitis: A Multicentre Randomised, Double-Blind, Placebo-Controlled, Non-Inferiority Trial
Clinical Microbiology and Infection
Medicine
Infectious Diseases
Microbiology
Novel, Single-Dose Microsphere Formulation of Azithromycin Versus 7-Day Levofloxacin Therapy for Treatment of Mild to Moderate Community-Acquired Pneumonia in Adults
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Memantine Treatment in Patients With Mild to Moderate Alzheimer's Disease: Results of a Randomised, Double-Blind, Placebo-Controlled 6-Month Study
Journal of Alzheimer's Disease
Gerontology
Clinical Psychology
Mental Health
Psychiatry
Geriatrics
Medicine
Neuroscience
The Effect of Simvastatin on Inflammatory Cytokines in Community-Acquired Pneumonia: A Randomised, Double-Blind, Placebo-Controlled Trial
BMJ Open
Medicine
Respiratory Fluoroquinolones vs. Other Commonly Used Antimicrobials in Mild-To-Moderate Severity Community-Acquired Pneumonia
The International Arabic Journal of Antimicrobial Agents
Early-Onset Ventilator-Associated Pneumonia in Adults Randomized Clinical Trial: Comparison of 8 Versus 15 Days of Antibiotic Treatment
PLoS ONE
Multidisciplinary
Severe Sepsis in Community-Acquired Pneumonia
Chest
Cardiology
Critical Care
Cardiovascular Medicine
Intensive Care Medicine
Pulmonary
Respiratory Medicine
Intramuscular Versus Oral Dexamethasone for the Treatment of Moderate-To-Severe Croup: A Randomized, Double-Blind Trial
Academic Emergency Medicine
Medicine
Emergency Medicine
Reducing Door-To-Antibiotic Time in Community-Acquired Pneumonia: Controlled Before-And-After Evaluation and Cost-Effectiveness Analysis
Thorax
Pulmonary
Respiratory Medicine
